[go: up one dir, main page]

ES8103072A1 - Cephem compounds, processes for their preparation and pharmaceutical compositions containing them. - Google Patents

Cephem compounds, processes for their preparation and pharmaceutical compositions containing them.

Info

Publication number
ES8103072A1
ES8103072A1 ES490504A ES490504A ES8103072A1 ES 8103072 A1 ES8103072 A1 ES 8103072A1 ES 490504 A ES490504 A ES 490504A ES 490504 A ES490504 A ES 490504A ES 8103072 A1 ES8103072 A1 ES 8103072A1
Authority
ES
Spain
Prior art keywords
preparation
alkyl
processes
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490504A
Other languages
Spanish (es)
Other versions
ES490504A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES490504A0 publication Critical patent/ES490504A0/en
Publication of ES8103072A1 publication Critical patent/ES8103072A1/en
Priority claimed from AU23283/84A external-priority patent/AU2328384A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Cephem compounds of the formula: < CHEM > wherein R<1> is amino or a protected amino, R<2> is lower alkyl, R<3> is hydrogen or lower alkyl, R<4> is hydrogen, acyloxy(lower)alkyl, acylthio(lower)alkyl or a heterocyclicthio(lower)alkyl which may be substituted with suitable substituent(s) and R<5> is carboxy or a protected carboxy, and pharmaceutically acceptable salt thereof and process for their preparation, and also a pharmaceutical composition comprising, as an effective ingredient, the above compound in association with a pharmaceutically acceptable, substantially non-toxic carrier or excipient. The invention also relates to the starting compounds < CHEM > and their preparation.
ES490504A 1978-07-10 1980-04-11 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them. Expired ES8103072A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB7829357 1978-07-10
GB7850334 1978-12-29
AU23283/84A AU2328384A (en) 1978-12-29 1984-01-13 1,2,4-thiadiazole derivatives

Publications (2)

Publication Number Publication Date
ES490504A0 ES490504A0 (en) 1981-02-16
ES8103072A1 true ES8103072A1 (en) 1981-02-16

Family

ID=32965858

Family Applications (3)

Application Number Title Priority Date Filing Date
ES482323A Expired ES482323A1 (en) 1978-07-10 1979-07-09 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them.
ES490503A Expired ES8103102A1 (en) 1978-07-10 1980-04-11 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them.
ES490504A Expired ES8103072A1 (en) 1978-07-10 1980-04-11 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES482323A Expired ES482323A1 (en) 1978-07-10 1979-07-09 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them.
ES490503A Expired ES8103102A1 (en) 1978-07-10 1980-04-11 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them.

Country Status (9)

Country Link
US (3) US4268509A (en)
EP (2) EP0007470B1 (en)
JP (1) JPS63264471A (en)
AR (1) AR226539A1 (en)
AU (1) AU533708B2 (en)
DE (1) DE2966293D1 (en)
DK (1) DK289079A (en)
ES (3) ES482323A1 (en)
HU (1) HU183010B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592149A (en) * 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
FR2387235A1 (en) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co PROCESS FOR THE PREPARATION OF COMPOUNDS OF 3,7-DISUBSTITUE-3-CEPHEM-4-CARBOXYLIC ACID AND NEW PRODUCTS THUS OBTAINED, HAVING A STRONG ANTIBACTERIAL ACTIVITY
US4390534A (en) 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
AU536842B2 (en) * 1978-12-29 1984-05-24 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin antibiotics
US4332798A (en) * 1978-12-29 1982-06-01 Fujisawa Pharmaceutical Co., Ltd. 7-Amino-thia-diazole oxyimino derivatives of cephem and cephem compounds
US4567275A (en) * 1978-12-29 1986-01-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds and processes for preparation thereof
US4331666A (en) * 1979-05-11 1982-05-25 Farmitalia Carlo Erba S.P.A. 3-[(8-Carboxy-6-tetrazolo[1,5-b]pyridazinyl)-thiomethyl]-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino-acetamido]-3-cephem-4-carboxylic acid
MA18891A1 (en) * 1979-07-05 1981-04-01 Ciba Geigy Ag AMINO-THIADIAZOLYL COMPOUNDS, PROCESS FOR THEIR PREPARATION
EP0025017A1 (en) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Polyazathia compounds, process for their preparation, pharmaceutical preparations containing such compounds and use of the latter
US4381299A (en) * 1980-03-07 1983-04-26 Fujisawa Pharmaceutical Co., Ltd. 7-Amino-thiadiazole oxyimino derivatives of cephem and cepham compounds
US4405617A (en) * 1980-02-11 1983-09-20 Fujisawa Pharmaceutical Co., Ltd. 3-(Propynyltetrazol)thiomethyl-3-cephems
GR78245B (en) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US4431642A (en) * 1980-12-01 1984-02-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4563449A (en) * 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
FR2729948A1 (en) * 1995-01-31 1996-08-02 Oreal NOVEL ARGININE DERIVATIVES, PREPARATION METHOD, USES AND COMPOSITIONS COMPRISING SAME
TW473479B (en) * 1997-12-19 2002-01-21 Takeda Chemical Industries Ltd Phosphonocephem derivatives, their production and use
US8673894B2 (en) 2010-05-07 2014-03-18 Hoffmann-La Roche Inc. 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
EP3616695B1 (en) 2011-09-09 2024-10-23 Merck Sharp & Dohme LLC Ceftolozane/tazobactam for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
UY35103A (en) 2012-10-29 2014-05-30 Glaxo Group Ltd 2-REPLACED CEFEM COMPOUNDS
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
EP2893929B1 (en) 2013-03-15 2025-04-16 Merck Sharp & Dohme LLC Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
BE791214A (en) * 1972-05-08 1973-05-10 Glaxo Lab Ltd PROCESS FOR PREPARING PURE ETHERIFIED HYDROXYIMINOACETIC ACID DERIVATIVES ISOMERS
DK154939C (en) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd METHOD OF ANALOGUE FOR THE PREPARATION OF THIAZOLYLACETAMIDO-CEPHEM COMPOUNDS OR PHARMACEUTICAL ACCEPTABLE SALTS OR ESTERS THEREOF
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
GB1592149A (en) 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
US4468515A (en) * 1978-12-29 1984-08-28 Fujisawa Pharmaceutical Co., Ltd. 2-Substituted oxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetic acids

Also Published As

Publication number Publication date
HU183010B (en) 1984-04-28
AR226539A1 (en) 1982-07-30
ES490504A0 (en) 1981-02-16
US4447429A (en) 1984-05-08
EP0036673B1 (en) 1984-07-11
ES482323A1 (en) 1980-08-16
EP0007470A2 (en) 1980-02-06
US4268509A (en) 1981-05-19
AU533708B2 (en) 1983-12-08
EP0007470A3 (en) 1980-04-16
DE2966293D1 (en) 1983-11-17
US4585872A (en) 1986-04-29
DK289079A (en) 1980-01-11
ES490503A0 (en) 1981-02-16
EP0007470B1 (en) 1983-10-12
EP0036673A1 (en) 1981-09-30
AU4869579A (en) 1980-02-07
ES8103102A1 (en) 1981-02-16
JPH0368028B2 (en) 1991-10-25
JPS63264471A (en) 1988-11-01

Similar Documents

Publication Publication Date Title
ES8103102A1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them.
ES8102140A1 (en) Cephem and cepham compounds, processes for their preparation, pharmaceutical compositions containing them.
ES8204739A1 (en) their starting compounds and their preparation.
ES8306160A1 (en) New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds.
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
DE3272792D1 (en) Process for the preparation of 2-penem compounds
ES8505690A1 (en) New cephem compounds and processes for preparation thereof.
DE3176274D1 (en) New cephem compounds and processes for preparation thereof
ES8300774A1 (en) New cephem compounds and processes for preparation thereof.
ES8405005A1 (en) New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof.
DE3363550D1 (en) New nitro aliphatic compounds, process for preparation thereof and use thereof
DE2964903D1 (en) 2-lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds, processes for their preparation and pharmaceutical compositions containing them
ES8404360A1 (en) 7-Acylamino-3-cephem-4-carboxylic acid derivatives, processes for the preparation of the same and pharmaceutical composition comprising the same.
ES8308569A1 (en) New cephem compounds and processes for preparation thereof.
DE2964634D1 (en) 3,7-disubstituted-2- or -3-cephem-4-carboxylic acid compounds, pharmaceutical compositions containing them and processes for the preparation thereof
ES8405409A1 (en) Beta-lactam derivatives.
ES8304923A1 (en) New peptide, process for preparation thereof and pharmaceutical composition containing it.
ES8302719A1 (en) New cephem compounds, processes for preparation thereof and pharmaceutical composition comprising the same.
ES8105734A1 (en) Clavulanic acid derivatives, process for their preparation and pharmaceutical compositions containing them.
DE2965943D1 (en) Cepham compounds, pharmaceutical compositions containing them and processes for the preparation thereof and of known cephem compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990301